脳深部刺激装置の世界市場規模：製品タイプ別、用途別、エンドユーザー別、地域範囲別および予測

脳深部刺激装置の市場規模と予測

脳深部刺激装置の市場規模は、2023年に14億6,000万米ドルと評価され、2026～2032年にかけてCAGR 9.20%で成長し、2032年には27億7,000万米ドルに達すると予測されています。

脳深部刺激装置（DBS）は、埋め込み電極を介して脳の特定部位に電気インパルスを送る医療機器です。これらの装置はパルス発生器と連動しており、通常は胸部の皮下に挿入されます。DBSは一般に、さまざまな神経疾患の治療効果がある異常な脳活動を制御するために使用されます。

DBSは一般に神経疾患、特にパーキンソン病やジストニアの治療に用いられます。パーキンソン病では、DBSは振戦、こわばり、徐脈などの運動症状を軽減し、患者のQOLを大幅に向上させます。ジストニアでは、DBSによって不随意筋収縮が抑制され、運動制御が可能になります。DBSはまた、強迫性障害（OCD）、てんかん、大うつ病性障害などの病気に対しても研究されており、その治療可能性はさらに高まっています。

脳深部刺激装置（DBS）の将来的な用途は、てんかん、大うつ病性障害、強迫性障害（OCD）など、より幅広い神経学的・精神医療的疾患の治療に拡大する可能性があります。刺激技術を改良し、治療効果を高める脳活動にリアルタイムで反応する適応型DBSシステムを開発するための研究が進行中です。さらに、神経画像と個別化医療の進歩により、患者の転帰を改善し、従来型DBS療法に伴う副作用を軽減する、オーダーメイドの刺激プロトコルが可能になる可能性があります。

脳深部刺激装置の世界市場力学

脳深部刺激装置の世界市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

神経疾患の有病率の増加：パーキンソン病、てんかん、ジストニアなどの神経疾患の有病率の増加が、DBS装置の需要を促進しています。人口の高齢化に伴い、これらの疾患の有病率は上昇すると予測され、効果的な代替治療に対する需要が高まっています。DBSは症状の治療や患者の生活の質の向上に役立つことが示されており、市場の拡大をもたらしています。

技術の進歩：より複雑な装置や洗練された刺激方法の開発など、DBS技術の革新により、治療の有効性と安全性が向上しています。脳の活動に基づいてリアルタイムで刺激を変更できる適応型DBS装置の開発は重要な成果です。このような技術は、患者の治療効果を高めると同時に悪影響を最小限に抑え、DBSを患者とヘルスケア提供者の双方にとってより望ましい選択肢にしています。

DBS療法に対する認識と受容の高まり：DBS療法の利点に関するヘルスケア専門家や患者の意識の高まりが、市場拡大の原動力となっています。教育プログラムやアドボカシー活動によって治療プロセスが解明され、その結果、受け入れが進んでいます。特に治療が限られている場合に、薬剤療法に代わる選択肢を求める患者が増えるにつれて、DBS装置の需要が高まり、市場の成長が促進されます。

主要課題

高い治療費：主要課題の1つは、DBS治療の高額な費用です。多くの患者は、機器の購入だけでなく、外科手術の設置や継続的なフォローアップ治療も受けられない可能性があります。この大きな経済的障壁は、特にヘルスケア資源が限られている新興諸国では、DBSへのアクセスを制限することが多いです。DBSの保険適用範囲はさまざまで、患者は償還を受けることが困難なため、治療へのアクセスが制限されることがあります。

規制上のハードル：DBS機器の規制上の認可手続きは、長くて複雑です。メーカーは厳格な規則に従い、安全性と有効性を実証するために徹底的な臨床検査を実施しなければなりません。そのため、製品導入の遅れや開発費の増加につながる可能性があります。さらに、国によってさまざまな規制規範があるため、さらに複雑さが増し、企業は製品を国際的に販売することが難しくなります。

臨床的限界とリスク：DBSは一部の疾患には有効であることが示されているが、適切な患者の不足や手術に伴う危険性の可能性から、その使用は限定的です。すべての患者がDBSに良好に反応するわけではなく、感染、装置の誤作動、神経学的問題などの副作用を発症する場合もあります。こうした臨床的制約は、患者やヘルスケア専門家がDBSを治療オプションとして使用することを思いとどまらせ、市場の成長に影響を与える可能性があります。

主要動向

技術の進歩：最も注目すべき動向の1つは、DBS技術の急速な開発です。リアルタイムの脳活動に刺激を適応させるクローズドループシステムが一般的になりつつあります。これらの装置は、患者固有のニーズに合った正確な電気インパルスを供給することで治療を最適化し、悪影響を最小限に抑えながら治療成績を向上させる可能性があります。さらに、電極設計と材料の進歩により、DBS装置の有効性と耐久性が向上しています。

用途の増加：もう一つの主要開発は、典型的な使用事例を超えたDBS応用の拡大です。DBSは主にパーキンソン病やジストニアの治療に使用されてきましたが、研究者はてんかん、強迫性障害（OCD）、大うつ病性障害など、さまざまな神経疾患や精神疾患の治療の可能性も調査しています。このような幅の広がりが需要を拡大し、市場成長の新たな機会を生み出しています。

認識と受容の高まり：潜在的な治療オプションとしてのDBSに関する知識の増加も市場成長の原動力となっています。教育活動や擁護団体がDBSの利点を広報し、その結果、ヘルスケア専門家や患者の間で受容性が高まっています。この動向は、さまざまな障害に対する安全かつ効果的な治療法としてDBSへの信頼を促進する優れた臨床結果や患者の証言によって裏付けられています。

目次

第1章 脳深部刺激装置の世界市場導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 脳深部刺激装置の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 脳深部刺激装置の世界市場：製品タイプ別

• 概要
• シングルチャネル脳深部刺激装置
• デュアルチャネル脳深部刺激装置

第6章 脳深部刺激装置の世界市場：用途別

• 概要
• パーキンソン病
• 本態性振戦
• ジストニア
• てんかん
• その他

第7章 脳深部刺激装置の世界市場：エンドユーザー別

• 概要
• 病院
• 外来手術センター
• 神経クリニック
• その他

第8章 脳深部刺激装置の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東・アフリカ

第9章 脳深部刺激装置の世界市場の競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第10章 企業プロファイル

• Boston Scientific Corporation
• Medtronic Plc
• Abbott Laboratories
• NeuroPace Inc
• Renishaw Plc
• Beijing PINS Medical Co. Ltd
• LivaNova PLC
• Nexstim
• Aleva Neurotherapeutics
• St. Jude Medical

第11章 主要開発

• 製品上市/開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第12章 付録

• 関連調査

Deep Brain Stimulation Devices Market Size And Forecast

Deep Brain Stimulation Devices Market size was valued at USD 1.46 Billion in 2023 and is projected to reach USD 2.77 Billion by 2032, growing at a CAGR of 9.20% from 2026 to 2032.

Deep Brain Stimulation Devices (DBS) are medical devices that send electrical impulses to specific brain regions via implanted electrodes. These devices are linked to a pulse generator which is normally inserted beneath the skin in the chest region. DBS is generally used to control aberrant brain activity which has therapeutic benefits for a variety of neurological diseases.

They are generally used to treat neurological illnesses, specifically Parkinson's disease and dystonia. In Parkinson's disease, DBS reduces motor symptoms such as tremors, stiffness, and bradykinesia, considerably increasing patients' quality of life. DBS can aid with dystonia by reducing involuntary muscle contractions allowing for more movement control. DBS is also being investigated for illnesses such as obsessive-compulsive disorder (OCD), epilepsy, and major depressive disorder, which increases its therapeutic potential.

The future uses of Deep Brain Stimulation Devices (DBS) may expand to treat a wider range of neurological and psychiatric disorders such as epilepsy, major depressive disorder, and obsessive-compulsive disorder (OCD). Research is ongoing to refine stimulation techniques and develop adaptive DBS systems that respond in real-time to brain activity enhancing treatment efficacy. Additionally, advancements in neuroimaging and personalized medicine could enable tailored stimulation protocols improving outcomes for patients and reducing side effects associated with traditional DBS therapies.

Global Deep Brain Stimulation Devices Market Dynamics

The key market dynamics that are shaping the global Deep Brain Stimulation Devices Market include:

Key Market Drivers:

Increasing Prevalence of Neurological Disorders: The increased prevalence of neurological diseases such as Parkinson's disease, epilepsy, and dystonia has fuelled demand for DBS devices. As populations age, the prevalence of these illnesses is predicted to rise, creating a higher demand for effective treatment alternatives. DBS has been shown helpful in treating symptoms and enhancing patients' quality of life, resulting in market expansion.

Technological Advancements: DBS technology innovations, such as the creation of more complex devices and refined stimulation procedures, are improving the treatment's effectiveness and safety. The development of adaptive DBS devices that can modify stimulation in real-time based on brain activity is a significant achievement. These technologies increase patient results while minimising negative effects, making DBS a more desirable option for both patients and healthcare providers.

Growing Awareness and Acceptance of DBS Therapy: Increased awareness among healthcare professionals and patients about the benefits of DBS therapy helps to drive market expansion. Educational programs and advocacy efforts are helping to demystify the treatment process, resulting in more acceptance. As more patients seek alternatives to medication, particularly when treatment is limited, demand for DBS devices rises, promoting market growth.

Key Challenges:

High Cost of Treatment: One of the main challenges is the high expense of DBS therapy. Many patients may be unable to afford the gadgets as well as surgical installation and continuing follow-up care. This significant financial barrier frequently restricts access to DBS, especially in developing countries where healthcare resources are limited. Insurance coverage for DBS varies, and patients may have difficulty receiving reimbursement restricting treatment access.

Regulatory Hurdles: The regulatory licensing process for DBS devices can be lengthy and complicated. Manufacturers must follow strict rules and conduct thorough clinical trials to demonstrate safety and efficacy. This might lead to delayed product introductions and higher development expenditures. Furthermore, various regulatory norms across countries add another layer of complexity making it difficult for companies to market their products internationally

Clinical Limitations and Risks: While DBS has shown beneficial for some illnesses, its use is limited because of a lack of appropriate patients and the possible hazards involved with surgery. Not all patients respond well to DBS, and some may develop side effects including infection, device malfunction, or neurological problems. These clinical constraints may dissuade patients and healthcare professionals from using DBS as a therapeutic option affecting market growth.

Key Trends:

Technological Advancements: One of the most noteworthy trends is the rapid development of DBS technology. Closed-loop systems which adapt stimulation to real-time brain activity, are becoming more common. These devices can optimize treatment by delivering precise electrical impulses suited to the patient's specific needs, potentially boosting outcomes while minimising negative effects. Furthermore, advances in electrode design and materials improve the efficacy and durability of DBS devices.

Increasing Applications: Another key development is the growth of DBS applications beyond their typical use cases. While DBS has predominantly been used to treat Parkinson's disease and dystonia, researchers are also investigating its potential for treating various neurological and psychiatric diseases such as epilepsy, obsessive-compulsive disorder (OCD), and major depressive disorder. This expanded breadth is increasing demand and creating new opportunities for market growth.

Growing Awareness and Acceptance: Increased knowledge of DBS as a potential treatment option is also driving market growth. Educational activities and advocacy groups are publicising the benefits of DBS, resulting in increased acceptability among healthcare professionals and patients. This trend is supported by excellent clinical outcomes and patient testimonials that promote faith in DBS as a safe and effective treatment for a variety of disorders

Global Deep Brain Stimulation Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Deep Brain Stimulation Devices Market:

North America:

North America dominates the deep brain stimulation (DBS) devices market due to its advanced healthcare infrastructure and strong expenditure in R&D. The presence of significant medical equipment manufacturers and cutting-edge technological advancements helps to accelerate the development of sophisticated DBS systems. Furthermore, the region has a strong regulatory structure that facilitates the approval and commercialization of medical devices enabling the availability of high-quality treatment choices for individuals with neurological illnesses.

Furthermore, the rising prevalence of disorders including Parkinson's disease, epilepsy, and depression in North America increases demand for DBS therapy. Growing awareness among healthcare professionals and patients about the usefulness of DBS in controlling various illnesses helps to drive market expansion. Collaboration among healthcare providers, researchers, and manufacturers creates a favorable climate for clinical trials and product introductions reinforcing North America's dominant position in the worldwide DBS device industry.

Asia-Pacific:

Asia Pacific is the fastest-growing region in the deep brain stimulation (DBS) devices market, owing to several factors including the rising prevalence of neurological illnesses such as Parkinson's disease, epilepsy, and depression. As the population ages, the prevalence of these disorders rises generating the need for effective treatments such as DBS. Furthermore, improved healthcare infrastructure in countries such as China and India increases access to innovative medical technologies which drives market growth.

Furthermore, the region is seeing tremendous investment in R&D, which is driving advancements in DBS technology. Governments and the commercial sector are working to promote neuromodulation medicines which are critical to improving patient outcomes. Increased awareness of DBS among healthcare professionals and patients combined with favorable reimbursement regulations is also helping to drive the market in Asia Pacific. This combination of increased demand, technological developments, and supporting healthcare regulations places Asia Pacific as a market leader for DBS devices.

Global Deep Brain Stimulation Devices Market: Segmentation Analysis

The Deep Brain Stimulation Devices Market is segmented based on Product Type, Application, End-User, and Geography.

Deep Brain Stimulation Devices Market, By Product Type

• Single-channel Deep Brain Stimulator
• Dual-channel Deep Brain Stimulator

Based on the Product Type, the Global Deep Brain Stimulation Devices Market is bifurcated into Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator. The dual-channel deep brain stimulator is more dominant in the Deep Brain Stimulation Devices Market. This dominance stems from its ability to target multiple brain regions simultaneously offering more effective treatment for complex neurological conditions. By allowing for independent programming of each channel, dual-channel stimulators enhance therapeutic outcomes and provide greater customization for patient needs. This versatility and improved efficacy make dual-channel devices the preferred choice among healthcare providers contributing to their increased market share over single-channel stimulators.

Deep Brain Stimulation Devices Market, By Application

• Parkinson's Disease
• Essential Tremor
• Dystonia
• Epilepsy
• Others

Based on Application, the Global Deep Brain Stimulation Devices Market is bifurcated into Parkinson's Disease, Essential Tremor, Dystonia, Epilepsy, and Others. In the Deep Brain Stimulation (DBS) Devices market, Parkinson's Disease is the most dominant indication. The significant prevalence of Parkinson's disease, along with its challenging motor symptoms such as tremors and rigidity, drives the demand for DBS as an effective treatment option. Additionally, the established efficacy of DBS in alleviating symptoms of Parkinson's enhances its adoption among healthcare providers. While other conditions like Essential Tremor and Dystonia also contribute to the market, Parkinson's remains the leading focus for DBS applications.

Deep Brain Stimulation Devices Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Neurological Clinics
• Others

Based on the End-User, the Global Deep Brain Stimulation Devices Market is bifurcated into Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others. Hospitals are the most dominant segment in the Deep Brain Stimulation Devices Market. They offer comprehensive neurological care, including specialized surgical procedures and post-operative support for patients undergoing deep brain stimulation. The presence of advanced medical facilities and experienced healthcare professionals in hospitals ensures proper device implantation and patient management. Additionally, hospitals are often involved in clinical trials and research contributing to advancements in DBS technology and treatment protocols which further solidifies their leading position in the market.

Deep Brain Stimulation Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Deep Brain Stimulation Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is more dominant in the deep brain stimulation (DBS) devices market due to advanced healthcare infrastructure, significant investment in research and development, and a high prevalence of neurological disorders such as Parkinson's disease and epilepsy. The presence of key market players and innovative technologies in the region fosters rapid advancements in DBS solutions. Additionally, favorable reimbursement policies and increasing awareness of DBS therapies among healthcare professionals and patients contribute to the growing adoption of these devices in North America.

Key Players

The "Global Deep Brain Stimulation Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, LivaNova PLC, Aleva NeuroTechnologies, Beijing PINS Medical Co., Ltd, SceneRay Co Ltd., and Michigan Tech Researchers.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Deep Brain Stimulation Devices Market Key Developments

• In June 2020, Percept, a deep brain stimulation device from Medtronic, was approved by the FDA. Brain Sense technology is used by the company to continuously capture, record, and monitor brain signals in individuals with neurological diseases. It has the potential to aid clinicians in tracking patient brain activity and enhancing data-driven, tailored neurostimulation treatment.
• In 2021, Abbott, received FDA approval for its new rechargeable deep brain stimulation system, the Liberta RC, which is noted for being the smallest and having the longest battery life among DBS devices. This innovation aims to enhance patient comfort and convenience by reducing the frequency of recharges.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Single-channel Deep Brain Stimulator
• 5.3 Dual-channel Deep Brain Stimulator

6 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET., BY APPLICATION

• 6.1 Overview
• 6.2 Parkinson's Disease
• 6.3 Essential Tremor
• 6.4 Dystonia
• 6.5 Epilepsy
• 6.6 Others

7 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers
• 7.4 Neurological Clinics
• 7.5 Others

8 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Boston Scientific Corporation
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Medtronic Plc
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Abbott Laboratories
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 NeuroPace Inc
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Renishaw Plc
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Beijing PINS Medical Co. Ltd
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 LivaNova PLC
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Nexstim
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Aleva Neurotherapeutics
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 St. Jude Medical
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research